I completed my bachelor’s degree at the University of British Columbia. I chose to then pursue a PhD at Gerstner Sloan Kettering because it offers a great translational aspect to the research. I am currently studying models of resistance to prostate cancer therapies. My work has led me to focus on prostate differentiation and epigenetic mechanisms of resistance in disease. The results so far include discovering new therapies that can target prostate cancer that is resistant to conventional antiandrogen therapies. On a personal level, I enjoy exploring New York City, skiing, and photography.
Grayer Fellowship (2013-2014)
Geoffrey Beene Graduate Student Fellowship (2012-2013)